Know What's Happening in BioTech
Know What's Happening in BioTech
BioTech Pulse
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
Merck scientists demonstrated that dielectric spectroscopy, measured as permittivity, can serve as an in‑line early‑warning system for apoptosis in CHO cell cultures. By analyzing Cole‑Cole model parameters—critical frequency (fc) and delta epsilon (Δε)—they captured stress‑induced shifts before conventional viability assays detected decline. Batch experiments showed fc rising and Δε falling during nutrient depletion, while perfusion runs linked similar patterns to shear stress and nutrient limitation. Implementing a control strategy that corrected fc deviations restored cell health and increased product output, highlighting the method’s practical value for biomanufacturing.
Scientists at Sartorius BIA Separations and Johannes Gutenberg University have introduced a low‑pH denaturation step that melts double‑stranded RNA (dsRNA) impurities in mRNA streams within seconds. By adjusting the pH to 3.5 or lower, dsRNA levels fall below 0.1% while...
New analysis highlights yeast-based protein expression as a promising vaccine platform for future pandemics. While mRNA and viral vector technologies enabled rapid COVID‑19 vaccine rollout, their high cost, manufacturing complexity, and cold‑chain requirements limited access in low‑income regions. Yeast systems...
The California legislature is poised to pass the Roman Reed Spinal Cord Injury Research Act, allocating $1 million annually for up to five years to revive the previously successful Roman’s Law. The original program funded $12.4 million in state grants, leveraged $82.4 million...
Researchers have identified the long non‑coding RNA LINC00857 as a driver of pancreatic ductal adenocarcinoma through a miR‑130b/RHOA signaling axis. The study shows LINC00857 is overexpressed in patient tumors and functions as a molecular sponge, sequestering miR‑130b and thereby upregulating...
Researchers have uncovered that small interfering RNA (siRNA) molecules are actively transported from the vegetative nucleus to sperm cells during pollen development, a process essential for proper gene silencing. The study, conducted in Arabidopsis thaliana, shows that disrupting siRNA transport...
Researchers led by Ryan Flynn have identified the cellular pathway that places glycoRNAs on the cell surface and demonstrated that these RNA‑glycan hybrids bind and inhibit VEGF‑A signaling. Genetic screens linked heparan sulfate to glycoRNA presentation, and loss of glycoRNAs...
University of British Columbia researchers engineered the native gut bacterium Bacteroides thetaiotaomicron to act as a continuous, noninvasive biosensor that glows brightly under normal conditions and dims when osmotic stress indicates malabsorption. Published in Cell, the study demonstrated in mice...
Google DeepMind unveiled AlphaGenome, a deep‑learning model that can process one million DNA bases in a single context, doubling the reach of its predecessor Borzoi. The system predicts eleven genomic functions at single‑base resolution, delivering a 14.7% improvement in gene‑activity...
The FDA placed a clinical hold on REGENXBIO’s RGX‑111 and RGX‑121 after a tumor was found in a five‑year‑old patient potentially linked to the AAV vector. The hold jeopardizes REGENXBIO’s Feb. 8, 2026 PDUFA deadline for its Hunter syndrome gene therapy. Denali...
Wondering why there's such a fuss about pushing some #vaccine recommendations to "shared clinical decision making"? The term is being conflated with "informed consent," suggesting it's about empowering parents. This isn't that; good take here. https://t.co/F0n0fYFczY https://t.co/h5VO475NmS
The U.S. Department of Health and Human Services announced a draft rule that would create a safe‑harbor exemption for drug manufacturers participating in the upcoming TrumpRx platform. The proposal seeks to shield companies from the federal anti‑kickback statute when they...
Reuters reports the Trump adminstration wants to condition any future funding to @gavi on the organization agreeing to phase out use of vaccines containing the preservative thimerosal. I wrote late last year about how unnecessary & impractical that would be....
Jiangsu Hengrui Pharmaceuticals has surged into the global top‑25 biopharma companies by market value, marking a dramatic shift from its previously low international profile. The Chinese firm leveraged a pipeline of innovative oncology and immunology drugs, securing multiple foreign regulatory...
1/ You think your ML model fails because it’s “not powerful enough”? No. It’s your data. Garbage in, garbage out. Here’s what most AI scientists miss when using public RNA-seq or single-cell data 👇 https://t.co/dVezFRLHkW
Halozyme Therapeutics announced a $300 million upfront acquisition of drug‑delivery biotech Surf Bio, adding its PEGylated enzyme platform to Halozyme’s existing portfolio. The deal is expected to broaden Halozyme’s subcutaneous biologics pipeline and accelerate commercialization of next‑generation delivery technologies. Concurrently, Sanofi...
Recent immunological research reveals that natural killer (NK) cells play a pivotal role in the severity of ankylosing spondylitis (AS). The study found a proportional increase in peripheral NK cell frequency and activation markers correlating with higher Bath Ankylosing Spondylitis...
The FDA approved Johnson & Johnson’s Darzalex Faspro as part of a four‑drug regimen for newly diagnosed multiple myeloma patients who cannot undergo stem cell transplantation. This is the drug’s twelfth overall and fifth frontline indication. Phase III CEPHEUS data showed 52.3%...
iXCells Biotechnologies is integrating Rosebud Biosciences’ AI‑driven organoid platform with its iPSC‑based iPSCore system to deliver scalable, three‑dimensional human tissue models. The partnership combines iXCells’ modular stem‑cell production with Rosebud’s reproducible organoid generation and characterization capabilities. Together they aim to...
Advanced Therapies Week 2026 in San Diego will spotlight the accelerating yet turbulent landscape of cell and gene therapies. New FDA guidance, including the plausible‑mechanism pathway, promises faster approvals, while recent U.S. cuts to mRNA projects and a wave of...
Recent studies identify CD81, a tetraspanin protein, as a key regulator of immune cell function in multiple myeloma. Patients exhibit reduced CD81 on T cells, impairing anti‑tumor responses, while higher overall CD81 levels correlate with improved survival and therapy response....
Cardiff Oncology announced the departure of its CEO and CFO while releasing mixed Phase II data for its PLK1 inhibitor onvansertib. In the CRDF‑004 trial, the 30 mg dose combined with FOLFIRI + bevacizumab achieved a 72.2% objective response rate and a 62% reduction...
Boehringer Ingelheim’s TRPC6 inhibitor apecotrep, originally a COVID‑19 candidate, achieved a 40% reduction in proteinuria versus placebo in a phase 2 trial for primary focal segmental glomerulosclerosis (FSGS). The study, published in The Lancet, provides the first efficacy signal for a...
The Biopharma Sentiment Index (BPSI) jumped to 90 in Q1 2026, up from 78 in the prior quarter, marking the strongest sentiment shift in four years. All ten core measures improved, driven chiefly by a surge in dealmaking and better access...
Researchers introduced photo‑activated ultrasound localization imaging (PAULI), using laser‑activated nanodroplets that vaporize into microbubbles for ultrasound detection. The method delivers micrometer‑scale spatial resolution and high contrast‑to‑noise ratios, surpassing traditional ultrasound. Activation is tunable via laser wavelength and pulse settings, allowing...
A recent clinical trial found that hydroxychloroquine does not improve key blood biomarkers in COVID-19 patients. The study measured inflammatory markers, cytokine levels, and viral load among hospitalized individuals with moderate disease severity. No statistically significant changes were observed compared...
Researchers led by Y. Otomo, R. Kimbara and K. Oguchi have documented a pronounced reduction in body segmentation of the skeleton shrimp *Caprella scaura*. By dissecting internal musculature and skeletal structures, the team demonstrated that this morphological simplification improves flexibility and maneuverability in...
Roche announced that its GLP‑1/GIP candidate CT‑388 achieved a 22.5% average weight loss in a Phase II study and will launch a Phase III trial early this year, pairing the drug with a Zealand Pharma therapy to curb gastrointestinal side effects. Baseline...
Eli Lilly has signed a global research and licensing deal with German gene‑editing startup Seamless Therapeutics to develop hearing‑loss treatments using Seamless’s programmable recombinase platform. The agreement grants Lilly exclusive rights to engineered recombinases that can insert large DNA fragments...
Eli Lilly has entered a partnership with Seamless Therapeutics, a startup pioneering recombinase‑based gene editing. The collaboration will combine Lilly’s drug development platform with Seamless’s proprietary recombinase enzymes to create precise, permanent DNA modifications for therapeutic applications. Under the agreement,...
Boehringer Ingelheim announced that its experimental oral therapy for a rare kidney disorder will advance to a pivotal Phase 3 trial. The decision follows a Phase 2 study that demonstrated modest improvements in glomerular filtration rate but produced puzzling efficacy signals across...
The Centers for Medicare & Medicaid Services released the third round of Medicare drug price negotiations, naming 15 drugs that will face mandatory discounts starting in 2028. The list, which adds Eli Lilly’s GLP‑1 therapy Trulicity and several physician‑administered products such...
Researchers examined APOE allele frequencies in “SuperAgers” versus Alzheimer’s disease patients and typical controls using the ADSP‑PHC multicohort dataset. Among non‑Hispanic White participants, SuperAgers displayed significantly fewer APOE‑ε4 alleles and a higher prevalence of the protective APOE‑ε2 allele compared with...
Heart disease and stroke together accounted for more than a quarter of all U.S. deaths in 2023, remaining the nation’s leading cause of mortality. Although overall death rates are improving post‑COVID, half of American adults still live with some form...
Researchers have introduced a green synthesis route for cerium oxide nanodots using debranched Curcuma longa starch, achieving uniform 2–4 nm particles. The starch acts as both reducing and stabilizing agent, eliminating the need for toxic solvents and high‑temperature steps. In vitro...
A new Dutch study finds that an HIV diagnosis significantly harms labor market outcomes. Diagnosed workers experience an average 12% wage reduction and an 8% higher unemployment risk within two years. The research attributes most losses to employer discrimination and...
Italy’s biotech sector, though less visible, hosts several companies poised for global impact in 2026. AAVantgarde Bio secured a $141 million Series B to launch dual‑AAV gene therapies for Stargardt disease and Usher syndrome, while Genenta Science rebranded as Saentra Forge to broaden...
A study in Nature Communications shows chemotherapy‑induced gut injury reshapes the microbiota, increasing production of the microbial metabolite indole‑3‑propionic acid (IPA). Elevated systemic IPA reaches the bone marrow, reprogramming myelopoiesis to lower immunosuppressive monocytes and boost T‑cell activity. In preclinical...
A recent multi‑criteria decision analysis by Cortés‑Vicente et al. evaluates Vyvgart® (efgartigimod alfa) for generalized myasthenia gravis (gMG) in Spain. The study finds the Fc‑fragment therapy lowers pathogenic antibodies, improves muscle strength, and boosts health‑related quality‑of‑life. Safety compares favorably to...
French researchers conducted a retrospective multicenter analysis of primary central nervous system lymphoma patients, linking hospital length of stay to survival outcomes. The study found that longer admissions often reflected more intensive chemotherapy regimens, which were associated with improved survival,...
In this episode, Marc Tessier‑Lavigne, co‑founder and CEO of Xaira, explains how the company is using an end‑to‑end AI platform to overhaul drug discovery by tackling three core bottlenecks: target selection, molecule design, and patient stratification. Xaira trains high‑dimensional "virtual...
Recent research has identified a stronger causal link between chronic exposure to the mycotoxin Ochratoxin A (OTA) and the development of hepatocellular carcinoma. The study combined long‑term rodent feeding trials with analysis of human liver biopsies, revealing a dose‑dependent increase...
A new ten‑year longitudinal study of 5,000 seniors found that individuals with poor oral hygiene were 30% more likely to develop dementia. Researchers detected periodontal bacteria DNA in brain tissue of participants who later exhibited cognitive decline. The analysis controlled...
Researchers have identified a distinct poorly differentiated subtype of pediatric chordoma, characterized by loss of SMARCB1 (INI1) expression and unique histologic features. Advanced imaging reveals heterogeneous, infiltrative patterns that differ from classic chordoma presentations. Early clinical data suggest that conventional...
A new multicondition profiling study demonstrates that traditional housekeeping genes are not uniformly stable across diverse biological states. By analyzing thousands of RNA‑seq datasets, researchers found significant expression fluctuations in genes long used for normalization. The findings call into question...
Health‑focused retailers are moving beyond flashy trends to a science‑led customer experience, where proof of efficacy replaces hype. Consumers in wellness, skincare and family‑health categories now demand clinical backing, clear ingredient origins and regulatory compliance before they commit. Brands like...
Researchers at a tertiary care center have completed comprehensive molecular profiling of metastatic and recurrent salivary gland carcinoma, identifying key gene mutations, copy-number changes, and fusions that correlate with tumor aggressiveness and patient survival. The study also maps the tumor...
Researchers have discovered that the antiviral drug zalcitabine can trigger ferroptosis, an iron‑dependent form of cell death, in multiple myeloma cells. Laboratory experiments showed significant lipid‑peroxide accumulation and loss of viability at micromolar concentrations. The effect was amplified when zalcitabine...
Corvus Pharmaceuticals reported Phase I efficacy for its oral ITK inhibitor soquelitinib in 24 atopic dermatitis patients who had failed prior therapies. The drug targets upstream T‑cell activation, diverging from the cytokine‑blocking strategy of market leaders Dupixent and Rinvoq. Investors...
In this episode, Javier Tordable, founder and CEO of Pauling.ai and former Google technologist, explains how modern large language models have evolved into autonomous AI agents capable of executing multi‑step scientific workflows, from literature synthesis to hypothesis generation and computational...
